In Italy, one in twenty adults aged 1869 years has been diagnosed with diabetes, and four in ten adults are overweight [1]
Nobody starts at the full dose
Theyve transformed diabetes care and opened new possibilities for long-term weight management, but they can be expensive without insurance
Some patients report that administering their GLP-1 injection in the evening, particularly after dinner, may help them manage early gastrointestinal side effects such as nausea, as they can sleep through the initial hours after injection
Overall, long-acting GLP-1 receptor agonists were more effective in reducing weight than short-acting formulations
Furthermore, GLP-1 augments mitochondrial efficacy, as manifested by the ameliorated oxidative metabolism of muscle tissue